Hope this note finds you and your family well as we round out 2023 and launch into a new year.
Your portfolio posted gains in November. It remains with positive performance over the past 12 months.
November was a strong and positive month for stocks and bonds in both Canada and the United States (U.S.).
The conversation has evolved into expectations of interest rate cuts in both Canada and the U.S. during the first half of 2024. In the U.S., this has led to an uptick in consumer confidence, and a continuation of the consumer spending that drives U.S. economic activity.
There is an index from the New York Federal Reserve called the Global Supply Chain Pressure Index. It tracks things such as shipping costs, backlogs and delivery times within the global transportation network. This index hit its lowest level on record in November, two years after soaring to all time highs in conjunction with supply side inflationary spike of 2021/2022.
If supply chain has largely been fixed, one should expect the path for inflation and interest rates to be lower in the future, not higher.
We expect these trends to continue to solidify in the months ahead. Taken together, they represent a tailwind for investment markets and economic activity.
We expect Canada to cut interest rates ahead of the U.S. on the path back down toward 3%. In this country, the catalyst for interest rate cuts will be slowing economic activity and protecting the economy from further contraction. In the U.S. interest rate cuts will add fuel to the new cycle of economic growth currently underway, without causing a renewed spike in inflation.
These long-term trends reinforce our existing investment strategy to prefer stocks in the U.S. and bonds and bond-like stocks in Canada.
You and your investments are in a strong position.
The view from Brian Belski, BMO's Chief Investment Strategist:
Stocks in your portfolio that made a new 52 week high this past month:
Accenture*, Microsoft*, S&P500 Index, Thomson Reuters*, Waste Management*, United Health*
Stocks in your portfolio that made a new 52 week low this past month:
Bristol-Myers*
The Loonie gained a cent and a half versus the U.S. dollar to:
$0.74
We wish you and your family all our best for a happy, healthy new year and beyond.